Marché mondial du syndrome d’hypersensibilité à la toux – Tendances et prévisions de l’industrie jusqu’en 2029

Analyse et taille du marché                              

Le réflexe de toux est un important mécanisme de protection contre l'aspiration, mais il peut devenir hypersensible s'il est mal géré. La toux chronique est en réalité une maladie grave avec un taux de morbidité élevé. Le syndrome d'hypersensibilité à la toux a maintenant reçu un paradigme unifié. Il s'agit d'une entité clinique dans laquelle la toux chronique est le symptôme principal, quelle que soit la maladie sous-jacente. Bien qu'il s'agisse encore d'une théorie, de nouvelles recherches révèlent que la neurophysiologie anormale est la cause la plus courante de cette maladie. Notre compréhension des mécanismes de la toux a évolué parallèlement à ce changement de paradigme au cours des dernières décennies, ce qui nous permet de faire encore plus de progrès à l'avenir.

Français Data Bridge Market Research analyse que le marché du syndrome d’hypersensibilité à la toux était évalué à 8,31 milliards USD en 2021 et devrait atteindre 13,15 milliards USD d’ici 2029, enregistrant un TCAC de 5,90 % au cours de la période de prévision de 2022 à 2029. En plus des informations sur le marché telles que la valeur du marché, le taux de croissance, les segments de marché, la couverture géographique, les acteurs du marché et le scénario du marché, le rapport de marché organisé par l’équipe de Data Bridge Market Research comprend également une analyse approfondie des experts, une épidémiologie des patients, une analyse du pipeline, une analyse des prix et un cadre réglementaire.

Portée du rapport et segmentation du marché

Market Definition

Cough is the most common sickness worldwide, according to the WHO. The treatment algorithm is shifting away from small compounds and toward biologics and natural treatments. Combination therapy have become increasingly common in recent years. Clinical trials are underway for the majority of industry-sponsored products. Cough hypersensitivity syndrome has a severe impact on patients' lives, including sleep disruption, vomiting, light-headedness, and even rib fractures. Infections, gastroesophageal reflux disease (GERD), asthma, and other factors can all contribute to it. Companies in the cough hypersensitivity syndrome treatment market are boosting the availability of babapentin and pregabalin, which are GABA-related chemicals that operate as neuromodulators for the treatment of neuropathic pain and epilepsy, because chronic cough produces greater bodily discomfort. Gabapentin has been reported to be well tolerated in placebo-controlled trials for the treatment of refractory persistent cough.

Cough Hypersensitivity Syndrome Market Dynamics

Drivers

• Increasing prevalence of chronic respiratory diseases

The rising prevalence of chronic respiratory diseases is anticipated to drive the cough hypersensitivity syndrome market's growth. Cough is a prevalent illness that affects millions of individuals throughout the world. Globally, the prevalence of chronic respiratory disorders is increasing, resulting in an increase in chronic cough problems. As a result, the expanding disease burden provides a bright future for the global market. Although some research suggest that other factors, such as asthma, smoking, a hot and humid atmosphere, and viral or bacterial illness, may increase the likelihood of getting cough.

• Increasing investment for healthcare infrastructure

Another significant factor influencing the growth rate of cough hypersensitivity syndrome market is the rising healthcare expenditure which helps in improving its infrastructure. Also, various government organizations aims to improve the healthcare infrastructure by increasing funding and this will further influence the market dynamics. Healthcare industries are investing in opiates and GABA (gamma-aminobutyric acid)-related substances to help people with cough hypersensitivity. To treat chronic intractable cough, opiates are excellent cough suppressants and have antitussive actions. Similarly, corporations are expanding their tramadol production capabilities, an opioid prescription with a chemical makeup comparable to codeine medicines.

Furthermore, surging geriatric population and sedentary lifestyle of people such as high addiction of smoking will result in the expansion of cough hypersensitivity syndrome market. Along with this, favourable reimbursement policies and rising number of government initiatives to spread awareness will enhance the growth rate of the market.

Opportunities

• Rising number of clinical trials

Over the forecast period, the cough hypersensitivity syndrome market is expected to develop due to an increase in the number of clinical trials for the treatment of cough hypersensitivity syndrome. This is anticipated to boost the new market opportunities. The recent success of a P2X3 receptor antagonist in randomized clinical trials is the first major advancement in cough treatments in 30 years; it finally gives a method for treating persistent cough as well as a useful tool for unravelling the mechanism underlying cough hypersensitivity.

Moreover, the market's growth is fueled by an increase in the number of research and development activities and emerging new markets. These factors will provide beneficial opportunities for the cough hypersensitivity syndrome market growth.

Restraints/Challenges

On the other hand, high cost associated with the treatment will obstruct the growth rate of market. The lack of healthcare infrastructure in developing economies and dearth of skilled professionals will challenge the cough hypersensitivity syndrome market. Additionally, lack of awareness among people and inefficiency of drugs along with its adverse effects will act as restrain and further impede the growth rate of market during the forecast period of 2022-2029.

This cough hypersensitivity syndrome market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the cough hypersensitivity syndrome market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Patient Epidemiology Analysis

Cough hypersensitivity syndrome market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analyses of epidemiology to market growth are analysed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.

COVID-19 Impact on Cough Hypersensitivity Syndrome Market

Since its emergence in December 2019, the COVID-19  virus has spread to nearly every country on the planet, prompting the World Health Organization (WHO) to declare it a public health emergency. COVID-19, a new coronavirus, was identified as the causal agent in the pneumonia cases. This virus spread quickly over the world, killing a large number of people. COVID-19 was labelled a global pandemic by the World Health Organization (WHO) in March 2020, and rigorous measures to prevent the disease's spread were recommended. Since then, the pandemic has delayed the expansion of the healthcare sector and disrupted the supply chain. Furthermore, governments in a number of nations had imposed nationwide lockdowns in order to halt the spread of COVID-19. Similarly, healthcare organizations in numerous nations throughout the world were having difficulty continuing their supply chain activities. The cough hypersensitivity syndrome market was hampered by the supply chain slowness. On the bright side, the cough hypersensitivity syndrome market is likely to improve as respective government bodies lifted the enforced lockdown restrictions. Various sectors are anticipated to rebound quickly post COVID-19 pandemic due to the wide number of applications they serve. As a result, the market is projected to stabilize in the future.

Global Cough Hypersensitivity Syndrome Market Scope

The cough hypersensitivity syndrome market is segmented on the basis of drug class, route of administration, end-users and distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Drug Class

• Inhales Corticosteroids
• Antitussive Agents
• Short-acting Beta-2 Agonists
• Anticholinergics
• Proton Pump Inhibitors
• Antihistamines
• Others

Route of Administration

• Oral
• Inhalation
• Others

End-Users

• Hospitals
• Specialty Clinics
• Homecare
• Others

Distribution Channel

• Hospital Pharmacy
• Retail Pharmacy
• Online Pharmacy
• Others

Cough Hypersensitivity Syndrome Market Regional Analysis/Insights

The cough hypersensitivity syndrome market is analyzed and market size insights and trends are provided by country, drug class, route of administration, end-users and distribution channel as referenced above.

The countries covered in the cough hypersensitivity syndrome market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America

North America dominates the cough hypersensitivity syndrome market in terms of market share and market revenue and will continue to flourish its dominance during the forecast period. This is due to the high prevalence of respiratory disorders and rising healthcare expenditure will further propel the market’s growth rate in this region. Additionally, growing focus of major key players on novel technology will further propel the market’s growth rate in this region.

Asia-Pacific is expected to grow during the forecast period of 2022-2029 due to surging number of population in this region. Also, development of healthcare infrastructure and rising government initiatives will further propel the market’s growth rate in this region.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Analyse du paysage concurrentiel et des parts de marché du syndrome d'hypersensibilité à la toux

Le paysage concurrentiel du marché du syndrome d'hypersensibilité à la toux fournit des détails par concurrent. Les détails inclus sont la présentation de l'entreprise, les finances de l'entreprise, les revenus générés, le potentiel du marché, les investissements dans la recherche et le développement, les nouvelles initiatives du marché, la présence mondiale, les sites et installations de production, les capacités de production, les forces et les faiblesses de l'entreprise, le lancement du produit, la largeur et l'étendue du produit, la domination des applications. Les points de données ci-dessus fournis ne concernent que l'orientation des entreprises liée au marché du syndrome d'hypersensibilité à la toux.

Certains des principaux acteurs opérant sur le marché du syndrome d’hypersensibilité à la toux sont :

• Akorn, Incorporated (États-Unis)
• Pfizer Inc. (États-Unis)
• GlaxoSmithKline plc (Royaume-Uni)
• Novartis SA (Suisse)
• Mylan NV (États-Unis)
• Teva Pharmaceutical Industries Ltd. (Israël)
• Sanofi (France)
• Boehringer Ingelheim International GmbH. (Allemagne)
• AstraZeneca (Royaume-Uni)
• Johnson & Johnson Private Limited (États-Unis)
• Bayer AG (Allemagne)
• Merck & Co., Inc. (États-Unis)
• Prestige Consumer Healthcare Inc. (États-Unis)
• F. Hoffmann-La Roche SA (Suisse)
• Société Bristol-Myers Squibb (États-Unis)
• Almirall, SA (Espagne)
• Zenomed Healthcare Private Limited (Inde)
• Cadila Pharmaceuticals (Inde)

SKU-53276